Routine Blood Tests Could Replace Colonoscopy
Tel Aviv U researchers discover that routine blood tests can provide an early warning for colorectal cancer.
Tel Aviv U researchers discover that routine blood tests can provide an early warning for colorectal cancer.

Researchers at Tel Aviv Universities are on track to finding a way to stop cancer cells from multiplying and spreading.

Leading international bio-medical experts will be presenting their findings at a conference in Jerusalem, with an eye toward personalized cures.

A group of teens and parents are in Israel - many for the first time–to celebrate recovery from cancer, thanks to Chai Lifeline & Hartman Family.

In a major breakthrough, scientists have found a gene that appears to be responsible for repeated relapses in a severe form of children’s leukemia.

Unique but not conclusive Israeli study indicates Holocaust survivors suffer from cancer more than those who came to Israel before Holocaust.

Israeli pharmaceutical giant Teva has signed a deal to invest $60 million in a new cancer-fighting drug to fight prostate and lung cancer.
A new cancer drug developed by Tel Aviv University researcher has been licensed for exclusive worldwide rights to develop and market the drug.

Scientists at the Technion have created a breath analysis test with an 86 percent success rate in detecting lung cancer.

Top cancer researcher Dr. David Sidransky brings innovative cancer treatment to Israel and believes it will lead in biotechnology as in hi-tech.
